Dual epidermal growth factor receptor and vascular endothelial growth factor receptor inhibition with vandetanib sensitizes bladder cancer cells to cisplatin in a dose- and sequence-dependent manner

✍ Scribed by Thomas W. Flaig; Lih-Jen Su; Caroline McCoach; Yuan Li; David Raben; Marileila Varella-Garcia; Lynne T. Bemis

• Book ID: 109055655
• Publisher: John Wiley and Sons
• Year: 2009
• Tongue: English
• Weight: 333 KB
• Volume: 103
• Category: Article
• ISSN: 1464-4096
• DOI: 10.1111/j.1464-410x.2009.08367.x